Role of extracellular subdomains of p185c-neu and the epidermal growth factor receptor in ligand-independent association and transactivation

We investigated the assembly and activation of the epidermal growth factor receptor (EGFR)–p185 c-neu heterodimer by using a sequential immunoprecipitation methodology. Using this approach we detected heterodimers and also higher-ordered oligomeric complexes. Phosphorylated EGFR–p185 c-neu heterodimeric forms were detected in the absence of EGF, but the species became highly phosphorylated after EGF stimulation. To evaluate heterodimer formation and additional transactivation by EGF, we investigated the roles of the four extracellular subdomains of p185 c-neu and the EGFR. Subdomains I–IV of the EGFR dimerized with subdomains I–IV of p185 c-neu , respectively, in a parallel manner. In addition, subdomains I–IV of the EGFR also associated with p185 c-neu subdomains III, IV, I, and II, respectively. A lack of one of the p185 c-neu cysteine-rich domains (subdomains II or IV) resulted in a loss of EGF-induced transactivation. These data suggest that two cysteine-rich domains play defining roles in ligand-dependent transactivation and that both of these cysteine-rich extracellular subdomains as well as non-cysteine-rich extracellular subdomains are involved in ligand-independent interactions with the EGFR. Our studies provide biochemical evidence of the role of the cysteine-rich domains of p185 c-neu in assembly and transactivation of erbB complexes and also indicate that these subdomains might be useful clinical targets. heterodimer cysteine-rich domain